Keeping Up: Genetics to Genomics in Four Editions

Illustration: A. Canamucio I knew, back in March, that I was taking a gamble. The fourth edition of my human genetics textbook would be published in July, and judging from the rate of genomes being sequenced, it looked like Homo sapiens might join the list come summer. Unless the new edition assumed that the project was completed, my book would be obsolete before it was printed. So I E-mailed the great and powerful J. Craig Venter, president of Celera Genomics Group in Rockville, Md., to ask ab

Written byRicki Lewis
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Illustration: A. Canamucio
I knew, back in March, that I was taking a gamble. The fourth edition of my human genetics textbook would be published in July, and judging from the rate of genomes being sequenced, it looked like Homo sapiens might join the list come summer. Unless the new edition assumed that the project was completed, my book would be obsolete before it was printed. So I E-mailed the great and powerful J. Craig Venter, president of Celera Genomics Group in Rockville, Md., to ask about the timetable.

Despite his image as Darth Vader--softened perhaps since the joint announcement on June 26 (see page 1)--Venter has always been exceptionally courteous to reporters. In my case, I had to do some rephrasing reminiscent of Bob Woodward and Carl Bernstein in All the President's Men to get him to admit that if a student were to read in late July that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform